Innovative Medical Technologies Surmodics is at the forefront of surface modification technologies for intravascular devices and provides advanced solutions for thrombotic and embolism treatments, presenting opportunities to collaborate on cutting-edge medical device development and integration.
Recent Product Launches The company has recently launched several innovative thrombectomy systems and a groundbreaking pulmonary embolism treatment, indicating ongoing product innovation and potential for expanding sales of these advanced therapeutic devices.
Expanding Market Presence With facilities in the United States and Ireland, Surmodics demonstrates geographic expansion that opens avenues for targeted sales efforts in international markets and regional healthcare networks.
Active Industry Engagement Participation in prestigious conferences like VIVA and TCT, along with published registry data, highlights Surmodics' commitment to industry leadership and provides multiple touchpoints for relationship building and product positioning.
Financial Growth Potential With revenues estimated between $100 million and $250 million and recent substantial funding, Surmodics is positioned for growth, making it a strategic partner for sales initiatives focused on innovative medical technology adoption.